Montvale, NJ16 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Montvale, NJ

Find 16 actively recruiting myalgic encephalomyelitis clinical trials in Montvale, NJ. Connect with local research sites and explore new treatment options.

16
Active Trials
1
Sponsors
3,158
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Montvale

About Myalgic Encephalomyelitis Clinical Trials in Montvale

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 16 myalgic encephalomyelitis clinical trials recruiting participants in Montvale, NJ. These studies are seeking a combined 3,158 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Montvale — FAQ

Are there myalgic encephalomyelitis clinical trials in Montvale?

Yes, there are 16 myalgic encephalomyelitis clinical trials currently recruiting in Montvale, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Montvale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Montvale research site will contact you about next steps.

Are clinical trials in Montvale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Montvale studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 16 active trials in Montvale are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov